Reduced intensity thiotepa-cyclophosphamide conditioning for allogeneic haemopoietic stem cell transplants (HSCT) in patients up to 60 years of age.

Reduced intensity thiotepa-cyclophosphamide conditioning for allogeneic haemopoietic stem cell transplants (HSCT) in patients up to 60 years of age.

Item
http://www.wikidata.org/entity/Q44427173
Current practice in total-body irradiation: results of a Canada-wide surveySecond EBMT Workshop on reduced intensity allogeneic hemopoietic stem cell transplants (RI-HSCT).Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant researchReduced-intensity conditioning followed by allogeneic hematopoietic cell transplantation in myeloid diseases.Thiotepa-based versus total body irradiation-based myeloablative conditioning prior to allogeneic stem cell transplantation for acute myeloid leukaemia in first complete remission: a retrospective analysis from the Acute Leukemia Working Party of thChronic myelogenous leukemia: role of stem cell transplant in the imatinib era.Antilymphocyte/thymocyte globulin for graft versus host disease prophylaxis: efficacy and side effects.Outcome of patients activating an unrelated donor search: the impact of transplant with reduced intensity conditioning in a large cohort of consecutive high-risk patients.Safety and efficacy of thiotepa-based conditioning for allogeneic transplantation in AML: a survey from the ALWP of the EBMT.Thiotepa-based conditioning for allogeneic stem cell transplantation in acute lymphoblastic leukemia-A survey from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.Reduced-intensity conditioning regimen with thiotepa and fludarabine followed by allogeneic blood stem cell transplantation in haematological malignancies.Outcome of allogeneic stem cell transplantation following reduced-intensity conditioninig regimen in patients with idiopathic myelofibrosis: the g.I.T.m.o. Experience.Alternative donor transplants for patients with advanced hematologic malignancies, conditioned with thiotepa, cyclophosphamide and antithymocyte globulin.Reduced-intensity conditioning using TBI (8 Gy), fludarabine, cyclophosphamide and ATG in elderly CML patients provides excellent results especially when performed in the early course of the disease.Allogeneic hemopoietic SCT for patients with primary myelofibrosis: a predictive transplant score based on transfusion requirement, spleen size and donor type.Long term complete remission of severe nephrotic syndrome secondary to diffuse global (IV-G) lupus nephritis following autologous, haematopoietic peripheral stem (CD34+) cell transplantation.Reduced intensity conditioning with thiotepa, fludarabine, and melphalan is effective in advanced multiple myeloma
P2860

Reduced intensity thiotepa-cyclophosphamide conditioning for allogeneic haemopoietic stem cell transplants (HSCT) in patients up to 60 years of age.

Item
http://www.wikidata.org/entity/Q44427173
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Reduced intensity thiotepa-cyc ...... atients up to 60 years of age.
@en
Reduced intensity thiotepa-cyc ...... opoietic stem cell transplants
@nl
type
label
Reduced intensity thiotepa-cyc ...... atients up to 60 years of age.
@en
Reduced intensity thiotepa-cyc ...... opoietic stem cell transplants
@nl
prefLabel
Reduced intensity thiotepa-cyc ...... atients up to 60 years of age.
@en
Reduced intensity thiotepa-cyc ...... opoietic stem cell transplants
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
Reduced intensity thiotepa-cyc ...... patients up to 60 years of age
@en
P2093
P2860
P304
P31
P356
10.1046/J.1365-2141.2000.02123.X
P407
P433
P478
P50
P577
P5875
P698